[期刊]
  • 《Current treatment options in oncology.》 2024年25卷4期

摘要 : Despite targeted therapy and immunotherapy being recognized as established frontline treatments for advanced non-small cell lung cancer (NSCLC), the unavoidable development of resistance and disease progression poses ongoing chall... 展开

相关作者
相关关键词